| Q38679035 | A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy |
| Q99419452 | A scalable method of determining physiological endotypes of sleep apnea from a polysomnographic sleep study |
| Q37720626 | Alternative approaches to treatment of Central Sleep Apnea |
| Q35615500 | An Integrative Model of Physiological Traits Can be Used to Predict Obstructive Sleep Apnea and Response to Non Positive Airway Pressure Therapy. |
| Q33793099 | An automated and reliable method for breath detection during variable mask pressures in awake and sleeping humans |
| Q45642627 | Another view of phenotypic evaluation in obstructive sleep apnea |
| Q38844382 | Application of Personalized, Predictive, Preventative, and Participatory (P4) Medicine to Obstructive Sleep Apnea. A Roadmap for Improving Care? |
| Q89741191 | Artificial intelligence in sleep medicine: Background and implications for clinicians |
| Q89037380 | Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnoea |
| Q38107387 | Clinical consequences of altered chemoreflex control. |
| Q35044703 | Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. |
| Q48148793 | Complex sleep apnea |
| Q37304390 | Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. |
| Q39928691 | Desipramine Increases Genioglossus Activity and Reduces Upper Airway Collapsibility during Non-REM Sleep in Healthy Subjects |
| Q43063041 | Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation |
| Q37352870 | Dynamic Drug-Induced Sleep Computed Tomography in Adults With Obstructive Sleep Apnea. |
| Q38668562 | Dynamic loop gain increases upon adopting the supine body position during sleep in patients with obstructive sleep apnoea |
| Q47747383 | Effects of Tiagabine on Slow Wave Sleep and Arousal Threshold in Patients With Obstructive Sleep Apnea |
| Q89478367 | Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits |
| Q34986911 | Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea |
| Q47747804 | Estimation of Pharyngeal Collapsibility During Sleep by Peak Inspiratory Airflow |
| Q89475229 | Feature Extraction of Upper Airway Dynamics during Sleep Apnea using Electrical Impedance Tomography |
| Q47695663 | Feedback modulation of surrounding pressure determines the onset of negative effort dependence in a collapsible tube bench model of the pharyngeal airway |
| Q59795841 | From CPAP to tailored therapy for obstructive sleep Apnoea |
| Q26827948 | Future of Sleep-Disordered Breathing Therapy Using a Mechanistic Approach |
| Q57808940 | Implication of mixed sleep apnea events in adult patients with obstructive sleep apnea-hypopnea syndrome |
| Q59132164 | Inherent vs. Induced Loop Gain Abnormalities in Obstructive Sleep Apnea |
| Q48013659 | Keep the airway open and let the brain sleep |
| Q47638462 | Knowledge Gaps in the Perioperative Management of Adults with Obstructive Sleep Apnea and Obesity Hypoventilation Syndrome. An Official American Thoracic Society Workshop Report. |
| Q38771024 | Loop Gain Predicts the Response to Upper Airway Surgery in Patients With Obstructive Sleep Apnea. |
| Q46328591 | Measuring Loop Gain via Home Sleep Testing in Patients with Obstructive Sleep Apnea. |
| Q37139775 | Model-based stability assessment of ventilatory control in overweight adolescents with obstructive sleep apnea during NREM sleep. |
| Q30384838 | Negative Expiratory Pressure Technique: An Awake Test to Measure Upper Airway Collapsibility in Adolescents |
| Q90325222 | Neural memory of the genioglossus muscle during sleep is stage-dependent in healthy subjects and obstructive sleep apnoea patients |
| Q30355448 | New Approaches to Diagnosing Sleep-Disordered Breathing. |
| Q48114210 | Night-to-night repeatability of supine-related obstructive sleep apnea |
| Q35976706 | Nonrapid Eye Movement-Predominant Obstructive Sleep Apnea: Detection and Mechanism |
| Q37530189 | Obstructive Sleep Apnea without Obesity Is Common and Difficult to Treat: Evidence for a Distinct Pathophysiological Phenotype |
| Q30422107 | Obstructive sleep apnea in older adults is a distinctly different physiological phenotype |
| Q49374416 | Obstructive sleep apnea: current perspectives. |
| Q28078503 | Obstructive sleep apnoea pathogenesis from mild to severe: Is it all the same? |
| Q56966291 | Opportunities for utilizing polysomnography signals to characterize obstructive sleep apnea subtypes and severity |
| Q43156658 | PSGs: more than just the AHI. |
| Q89726873 | Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA Overlap syndrome versus OSA alone |
| Q38219952 | Pathophysiology of human ventilatory control |
| Q47645774 | Phenotyping Pharyngeal Pathophysiology Using Polysomnography in Patients with Obstructive Sleep Apnea |
| Q47646878 | Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature |
| Q47760039 | Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study |
| Q26991606 | Physiological effects of obstructive sleep apnea syndrome in childhood |
| Q26829148 | Physiology in medicine: obstructive sleep apnea pathogenesis and treatment--considerations beyond airway anatomy |
| Q47222068 | Quantifying the Arousal Threshold using Polysomnography in Obstructive Sleep Apnea |
| Q30405667 | Quantifying the ventilatory control contribution to sleep apnoea using polysomnography |
| Q96431930 | Recent advances in the management of secondary hypertension-obstructive sleep apnea |
| Q46231918 | Response to a combination of oxygen and a hypnotic as treatment for obstructive sleep apnoea is predicted by a patient's therapeutic CPAP requirement |
| Q42353190 | Sleep Apnea in Familial Dysautonomia: A Reflection of Apnea Pathogenesis |
| Q90377678 | Sleep quality in survivors of critical illness |
| Q47245155 | Stable Breathing in Patients With Obstructive Sleep Apnea Is Associated With Increased Effort but Not Lowered Metabolic Rate. |
| Q38962716 | The Combination of Anatomy and Genioglossus Activity in Predicting the Outcomes of Velopharyngeal Surgery |
| Q37351255 | The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility. |
| Q35936381 | The Effect of Body Position on Physiological Factors that Contribute to Obstructive Sleep Apnea. |
| Q47699676 | The effects of arousal accompanying an apneic event on blood pressure and sympathetic nerve activity in severe obstructive sleep apnea. |
| Q45802193 | The human upper airway: more than a floppy tube |
| Q36089133 | The importance of obstructive sleep apnoea and hypopnea pathophysiology for customized therapy |
| Q41970894 | The ongoing need for good physiological investigation: obstructive sleep apnea in HIV patients as a paradigm |
| Q33708781 | Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold |
| Q33772394 | Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy |
| Q34524490 | Treatments for Obstructive Sleep Apnea |
| Q89287564 | Understanding Pathophysiological Concepts Leading to Obstructive Apnea |
| Q33679035 | Understanding Phenotypes of Obstructive Sleep Apnea: Applications in Anesthesia, Surgery, and Perioperative Medicine |
| Q46162109 | Upper-Airway Collapsibility and Loop Gain Predict the Response to Oral Appliance Therapy in Patients with Obstructive Sleep Apnea. |
| Q47781058 | Velopharyngeal mucosal surface topography in healthy subjects and subjects with obstructive sleep apnea. |